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Crystal structure and site‑directed 
mutagenesis of circular bacteriocin 
plantacyclin B21AG reveals cationic 
and aromatic residues important 
for antimicrobial activity
Mian‑Chee Gor1,2,9, Ben Vezina1,9, Róisín M. McMahon1, Gordon J. King3, Santosh Panjikar4,5, 
Bernd H. A. Rehm1,6, Jennifer L. Martin1,7 & Andrew T. Smith1,8*
Plantacyclin B21AG is a circular bacteriocin produced by Lactiplantibacillus plantarum B21 which 
displays antimicrobial activity against various Gram‑positive bacteria including foodborne pathogens, 
Listeria monocytogenes and Clostridium perfringens. It is a 58‑amino acid cyclised antimicrobial 
peptide, with the N and C termini covalently linked together. The circular peptide backbone 
contributes to remarkable stability, conferring partial proteolytic resistance and structural integrity 
under a wide temperature and pH range. Here, we report the first crystal structure of a circular 
bacteriocin from a food grade Lactobacillus. The protein was crystallised using the hanging drop 
vapour diffusion method and the structure solved to a resolution of 1.8 Å. Sequence alignment against 
18 previously characterised circular bacteriocins revealed the presence of conserved charged and 
aromatic residues. Alanine substitution mutagenesis validated the importance of these residues. 
Minimum inhibitory concentration analysis of these Ala mutants showed that  Phe8Ala and  Trp45Ala 
mutants displayed a 48‑ and 32‑fold reduction in activity, compared to wild type. The  Lys19Ala mutant 
displayed the weakest activity, with a 128‑fold reduction. These experiments demonstrate the relative 
importance of aromatic and cationic residues for the antimicrobial activity of plantacyclin B21AG and 
by extension, other circular bacteriocins sharing these evolutionarily conserved residues.
Bacteriocins are a group of ribosomally-synthesised antimicrobial peptides produced by both Gram-negative 
and Gram-positive bacteria. They generally confer antimicrobial activity against bacterial species and/or strains 
closely related to the bacteriocin producers. Many  studies1–4 have suggested that these antimicrobial peptides 
have potential as natural food preservative. Bacteriocins have also been identified as possible next generation 
antibiotics to combat multiple-drug resistant  pathogens3,5. In recent years, bacteriocins from Gram-positive 
bacteria, especially lactic acid bacteria (LAB) have attracted interest because they are generally regarded as safe 
(GRAS) for human consumption and are thought to have a broader antimicrobial spectrum than bacteriocins 
produced by Gram-negative  bacteria6. Furthermore, Gram-positive bacteriocins are active against foodborne 
pathogens, making them important candidates for controlling food spoilage and pathogenic bacteria in the food 
and pharmaceutical  industries6.
Bacteriocins produced by Gram-positive bacteria are divided into three main classes: class I—modified, 
class II—unmodified and class III—large, heat  labile7. Of these, circular bacteriocins (class I) have gained atten-
tion due to their unique characteristics of high thermal and pH stability, as well as resistance to degradation by 
many proteolytic enzymes. The covalently linked N- and C-termini form a structurally distinct cyclic peptide 
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 backbone8. There are 20 circular bacteriocins reported in the literature to date, all are between 58 to 70 amino 
acids in length, corresponding to approximately 5.6 to 7.2 kilodalton (kDa) in  mass9,10. They are clustered into 
two families based on sequence similarity and biochemical characteristics. Family I bacteriocins are more cationic 
and have a higher isoelectric point (pI ~ 10) whereas members of family II are more hydrophobic and have a 
lower isoelectric point (pI ~ 5)8,11. Family I includes aureocyclicin  418512, enterocin NKR-5-3B13 ,  amylocyclicin14, 
amylocyclicin  CMW115, enterocin AS-4816, bacteriocin  2117(identical to AS-48), carnocyclin  A18, circularin  A19, 
thermocin  45820, garvicin  ML21, lactocyclicin  Q22, leucocyclicin  Q23,  pumilarin9,  uberolysin24 and  cerecyclin25. 
These bacteriocins are found across a wide range of Gram-positive genera. Family II are generally found in 
Lactobacillus, Staphylococcus and Streptococcus species, and includes gassericin A/reutericin  626, butyrivibriocin 
 AR1027, acidocin  B28,  paracyclicin29, plantaricyclin  A30 and plantacyclin  B21AG31–33.
Until now, the only bacteriocin crystal structure reported was that of enterocin AS-48, which was solved by 
single isomorphous replacement with anomalous scattering (SIRAS)34. By comparison there are many Nuclear 
Magnetic Resonance (NMR) structures of  bacteriocins35. For example, NMR solution structures have been 
reported for family I enterocin AS-48, carnocyclin A, enterocin NKR 5-3B and family II, acidocin B. Despite low 
sequence similarity, all the NMR and crystal structures demonstrate a conserved structural motif consisting of 
four to five α-helices encompassing a hydrophobic core, with the C-teminus and N-terminus ligation occurring 
within an α-helix secondary  structure11. The circular nature of these proteins contributes to remarkable stability 
against physical  stresses8,36. The conformational and thermal stability of the circular enterocin AS-48 compared to 
its linear counterpart,  AS10/11 obtained by limited proteolysis have been demonstrated  previously37. For example, 
the linear  AS10/11 has 35% lower α-helical content compared with the native circular protein (measured by Far-UV 
circular dichroism (CD)). Linear  AS10/11 is less compact and rigid compared to circular AS-4838. Linear  AS10/11 at 
pH 2.5 showed a low cooperativity of thermal unfolding and reduced stability compared to the circular AS-48, 
which was shown to unfold at 102 °C39,40. The linear  AS10/11 retained some antimicrobial activity although it was 
300 times lower than the circular AS-48, suggesting that circularisation is not essential for bactericidal activity 
but more importantly for stabilisation of the three-dimensional structure of the  bacteriocin37. Similarly, the linear 
version of AS-48, Trp70Ala mutant has just 18% helical structure compared to 72% in the circular AS-48, as 
measured by far-UV CD. Circular AS-48 is extremely stable in comparison with its linear counterpart, with no 
sigmoidal transition observed between 25 and 95 °C, whereas linear Trp70Ala mutant had a melting temperature 
of 61 °C41. These structurally stable circular bacteriocins and their mechanism of circularisation are of interest 
because of their biotechnological properties and applications. Proteins with new or improved features including 
enhanced stability could be generated through protein engineering, though this requires a deep understanding 
of bacteriocin structure–function  relationships18,38.
We previously identified a circular bacteriocin plantacyclin B21AG from Lactiplantibacillus plantarum B21 
(previously known as Lactobacillus plantarum)42. This family II circular bacteriocin has antimicrobial activity 
against foodborne pathogens including Listeria monocytogenes and Clostridium perfringens and other closely 
related Lactobacillus  species31. We have also cloned the plantacyclin B21AG gene cluster into a plantacyclin 
B21AG-negative strain and used this system for its  expression43. In the present study, we report the crystal 
structure of plantacyclin B21AG. Using this crystal structure, we identified by structural bioinformatics several 
conserved residues and showed via site-directed mutagenesis that these residues contribute to bactericidal func-
tion. Only one crystal structure has been reported for an enterocin AS-48, from bacteriocin family I which is 
evolutionarily quite distinct from family II circular  bacteriocins10. Elucidation of the structure of plantacyclin 
B21AG could therefore provide new information in understanding the structure and function of these fascinat-
ing proteins. To the best of our knowledge, this is the first report of a crystal structure of a family II circular 
bacteriocin, and the first of a bacteriocin produced by a food grade LAB.
Results and discussion
Crystal structure of plantacyclin B21AG. Crystals of plantacyclin B21AG suitable for structure deter-
mination grew from hanging drop vapour diffusion using a well solution of 1.1 M sodium malonate, 0.1 M 
HEPES buffer pH 7.0 and 0.5% v/v Jeffamine ED-2003. A crystal from these conditions diffracted to 1.8  Å 
resolution and belonged to the space group  C2221. Crystallographic statistics for data collection/processing and 
refinement are shown in Table 1. The crystal structure diffraction data were phased by molecular replacement 
using a theoretical α-helix (8 residues long polyalanine) as a search model. The structure was refined to a final 
 Rwork/Rfree of 0.169/0.215 at 1.8 Å resolution. There are two independent molecules of plantacyclin B21AG in the 
asymmetric unit. The structures of these two molecules (Chain A and Chain B) are similar to each other, with a 
 Cα backbone root-mean-square deviation, RMSD of 0.56 Å across 58  Cα atoms (Fig. 1a). 
The structure of plantacyclin B21AG is characterised by four α-helices, i.e.  Thr14–Ser26 (α1),  Leu30–Leu38 (α2), 
 Gly44–Ala52 (α3) and  Gly54–Phe8 (α4). Helix α1 and helix α4 are linked covalently between  Ile1 and  Ala58 in the 
middle of helix α4, creating a circular backbone (Fig. 1a). The four α-helices in the crystal structure are connected 
by loops of 1 to 6 residues and enclose a hydrophobic core in a tightly folded globular arrangement (Fig. 1b). 
Together, the loops contain five surface exposed glycine residues i.e.  Gly9,  Gly27,  Gly39,  Gly54 and  Gly55. Glycines 
are often found in flexible loop regions as they do not contain a side chain, increasing the conformational flex-
ibility (demonstrated by NMR solution structures of other circular bacteriocins)13,28,44. The hydrophobic core 
residues are  Ile1,  Ile4,  Ala5,  Val10,  Leu12,  Ala20,  Leu24,  Leu30,  Val33,  Ala34,  Ile37,  Leu38,  Val40,  Leu42,  Ala46,  Ala50 and 
 Ala58. All of these residues have < 20% solvent exposure calculated based on  GETAREA45. The second, third and 
fourth α-helices are predominantly hydrophobic, with the linked amino acids at the N- and C-termini in helix α4 
buried in the core of the structure. In contrast, helix α1 is amphipathic, with hydrophilic residues  (Thr14,  Gln18, 
 Ser25 and  Ser26) exposed at the surface of the protein.
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The protein has an overall net charge of + 3 at physiological pH, with four cationic residues located in helix 
α1  (Lys15 and  Lys19), helix α4  (Arg6) and the loop connecting α1/α4  (His11), and one anionic residue located in 
helix α1  (Asp22) (Fig. 1c, upper panel). These charged residues are all displayed on the surface of the plantacyclin 
B21AG structure. The electrostatic potential surface map of plantacyclin B21AG reveals two cationic patches 
separated by an anionic strip (Fig. 1c, lower panel).
Structural comparisons of circular bacteriocins. To better understand the similarities and differences 
between known structures of circular bacteriocins, structural comparisons were performed between plantacyc-
lin B21AG and other bacteriocin 3D structures elucidated to date, namely enterocin AS-48, carnocyclin A and 
enterocin NKR-5-3B (family I) and acidocin B (family II). We note that the acidocin B structure was determined 
using the bacteriocin embedded in SDS  micelles28, whereas the other bacteriocin structures were determined 
under aqueous  conditions13,34,44. These circular bacteriocins adopt a common 3D structure comprising four or 
five helices folded into a globular bundle enclosing a hydrophobic  core11 (Fig. 2, left panel)13,28,34,44. The orienta-
tion of the helices is similar within the members of each family, with the exception of enterocin AS-48 which 
has five rather than four α-helices. Notably, the circularisation point for all these bacteriocins is located within 
a helical structure which contains mostly hydrophobic  residues36. Analysis of solvent exposed residues using 
 GETAREA45 reveals that the N- to C-linkage of all these bacteriocins except the micelle embedded acidocin B 
is buried in the protein core (the ratio of side chain surface area to the average solvent-accessible surface area 
of the first and last amino acid, respectively is less than 20%). Unlike saposins and saposin-like peptides which 
are stabilised by disulfide bonds between cysteine  residues46, the bacteriocin helical fold appears to be stabilised 
by hydrophobic side chain interactions upon peptide  circularisation44. Martin-Visscher et al.44 proposed that 
hydrophobic residues close to the N–C linkage may play a role in the interaction between the linear peptide 
and the cyclisation enzyme, helping to bring the termini into close proximity for cyclisation to take place. A 
combination of circular backbone and hydrophobic core is thought to contribute to the stability of circular 
 bacteriocins13.
Surface characteristics of circular bacteriocins. The molecular surface of the circular bacteriocins 
is amphipathic: one face of the molecule has cationic and anionic patches, and the other surface is uncharged 
Table 1.  Data collection and refinement statistics for the crystal structure of plantacyclin B21AG. The number 
of crystals used for structure determination and refinement is one. a Highest resolution shell is shown in 
parenthesis.
Data collection
Space group C2221
Cell dimensions
 a, b, c (Å) 44.13, 93.17, 49.49
 α, β, γ (°) 90, 90, 90
Resolution (Å) 46.58–1.80 (1.84–1.80)a
No. observations 128,402
No. reflections 9770
Rmerge 0.074 (0.730)
Rpim 0.030 (0.306)
I/σI 15.5 (2.4)
Completeness (%) 99.8 (96.7)
Redundancy 13.1 (12.3)
Refinement
Resolution (Å) 46.58–1.80
No. reflections 9770
Rwork/Rfree 16.9%/21.5%
No. atoms
 Protein 802
 Ligand/ion 7
 Water 56
B-factor
 Protein 26.1
 Ligand/ion 21.6
 Water 39.2
R.m.s. deviations
 Bond lengths (Å) 0.019
 Bond angles (°) 1.697
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or hydrophobic (Fig. 2, right panel). Generally, family I circular bacteriocins are more cationic than family II 
circular bacteriocins (Table 2). Noteworthy is the cationic region located close to the N- and C-ligation point 
(α1 and α4). This cationic region is present in enterocin AS-48, carnocyclin A and enterocin NKR-5-3B. Eight 
lysine residues are located along the stretch of α4 and α5 in enterocin AS-48. Similarly, four lysine residues 
are located along α3 and α4 of carnocyclin A and enterocin NKR-5-3B (Fig. 2, right panel). The surface rep-
resentation of the circular bacteriocins presented in Fig. 2 suggests that the charge distribution is conserved 
among circular  bacteriocins13. The cationic surface patches are thought to be involved in an initial electrostatic 
interaction between the peptide and the negatively charged phospholipid bilayer of target cell  membranes8,13,36. 
Binding of the cationic regions onto the target membrane may result in destabilisation of the membrane, poten-
tially enabling peptide  insertion44. However, it has also been demonstrated that electrostatic interaction alone is 
insufficient for antimicrobial activity. A 21-residue peptide fragment of enterocin AS-48 containing the cationic 
putative membrane interacting region exhibited competitive membrane  binding47 but did not show antibacterial 
activity, suggesting that other physicochemical properties of the bacteriocins may be required for antimicrobial 
action.
Most of the bacteriocin anionic residues are located in close proximity to the cationic patches (Fig. 2, right 
panel). Whilst the role of anionic residues are generally overlooked in the context of circular bacteriocins, stud-
ies have shown that mutation of anionic residues in other classes of bacteriocins and/or antimicrobial peptides 
resulted in reduced bactericidal potency and altered target cell  specificity48,49. Replacing aspartic acid at position 
17 with the glutamic acid strongly enhanced the antimicrobial activity of the pediocin-like bacteriocin sakacin 
P. This result suggests that the anionic residues interact in a structurally specific and restricted manner with a 
cationic region on the target cell or on the peptide  itself50. Given that circular bacteriocins have been found to 
kill through disruption of proton motive force and pore  formation51–53, it is likely that their conserved structural 
similarities will result in the placement of negative charges near the pore so as to facilitate pore selectivity and 
cation flow out of the target cell by reducing the electrostatic energy profile and increasing selectivity for divalent 
cations such as  Ca2+54. These findings suggest that anionic residues are as important as cationic residues in terms 
of target specificity of the bacteriocins.
The Grand Average of Hydropathy (GRAVY)  Index55 calculation reveals that family II circular bacteriocins are 
more hydrophobic than those in family I—except Carnocyclin A (Table 2). The hydrophobicity of plantacyclin 
B21AG is evident in that it selectively dissolves into butanol fractions during purification. Some hydrophobic 
residues are exposed at the surface of the molecules (Fig. 2, right panel). The hydrophobicity of these peptides is 
thought to be crucial for creating pores in the bacterial membrane, especially for family II bacteriocins as they are 
less  cationic28,46 (Table 2). Permeation of the cell membrane by these peptides causes leakage of ions, dissipation 
of membrane potential and eventually cell  death8. The molecular mode of action of enterocin AS-48 has been 
widely studied and is the best understood of the circular bacteriocins. A model has been  proposed34 such that 
the peptide in the form of a water-soluble dimer approaches the membrane surface of target bacteria through 
electrostatic interaction. Upon membrane interaction, each protomer within the water-soluble dimer rotates 
90° and rearranges such that the hydrophobic helices become solvent accessible. The transition of AS-48 from 
water-soluble dimer to membrane-bound dimer allows the bacteriocin to insert into the bacterial membrane. 
This insertion alters the membrane potential, causing pore formation and cell  leakage34,47,52. Collectively, these 
 studies34,47,52 have shown that cationic patches and hydrophobic patches play an important role in the mechanism 
of action of bacteriocins.
Structural alignment of circular bacteriocins. Structural alignment using the align function in 
 PyMOL56 revealed that the three-dimensional structure of family II plantacyclin B21AG aligned well with family 
I enterocin NKR5-3B, with a r.m.s.d of 2.47 Å across 30  Cα atoms. For both structures, the helices α1, α2 and α4 
are similar in length and align in parallel in a similar orientation. α3 of enterocin NKR5-3B is twice the length of 
α3 of plantacyclin B21AG but is oriented similarly (Fig. 3). The alignment of plantacyclin B21AG with enterocin 
NKR5-3B suggests that family I and family II bacteriocins could share a conserved three-dimensional structure 
with a very similar core fold, despite low sequence identity (15.6%) (Fig. 4). In contrast, there is poor structural 
alignment between plantacyclin B21AG and enterocin AS-48 with r.m.s.d of 4.54 Å across 45  Cα atoms (Fig. 3) 
(sequence identity 11.4%, Fig. 4). AS-48 also has a longer sequence than plantacyclin B21AG (70 residues com-
pared with 58) and forms five α-helices rather than four (Fig. 2). Similarly, plantacyclin B21AG and carnocyclin 
A do not align well, with r.m.s.d of 4.33 Å across 45  Cα atoms (Fig. 3) (sequence identity 16.7%, Fig. 4).
Figure 1.  Structural characteristics of plantacyclin B21AG. (a) Superposition of Chain A (magenta) and Chain 
B (yellow) of the crystal structure of plantacyclin B21AG. The blue dashed line indicates the N-to-C cyclisation 
point. (b) Hydrophobicity of plantacyclin B21AG. In this figure, the side chain atoms of hydrophobic residues 
(Ala, Ile, Leu, Phe, Pro, Gly, Trp and Val) are coloured in yellow. All other atoms of the same residues and all 
atoms of non-hydrophobic residues are shown in grey. Upper panel: Ribbon diagram illustrating the compact, 
hydrophobic core of plantacyclin B21AG. Hydrophobic side chains are drawn as sticks; Lower panel: Surface 
representation showing the solvent exposed hydrophobic side chains. (c) Ribbon diagram (upper panel) and 
electrostatic potential (lower panel) depicting amphipathicity of plantacyclin B21AG at physiological pH. In the 
ribbon diagram, side chain atoms of the cationic and anionic residues are depicted in blue (Arg, Lys and His) 
and red (Asp), respectively. All other atoms of the same residues and all atoms of neutral residues are shown 
in grey. Electrostatic potential calculated by APBS  function84 using PDB2PQR version 2.1.185 and surface map 
generated with Chimera 1.1486. Cationic, anionic and neutral residues are depicted in blue, red and white, 
respectively. Key residues are labelled with single amino acid codes and residue numbers.
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Figure 2.  Three dimensional structural features of circular bacteriocins. Left panel: The helical orientation 
of the four/five α-helices is shown as α1 (blue), α2 (green), α3 (yellow), α4 (red) and α5 (orange). The black 
arrows indicate the orientation of the α helices. The dotted black lines represent the linkage between the N- 
and C-terminal. Right panel: Surface representation of the protein structures depicting side chain atoms of 
hydrophobic residues (yellow), cationic residues (blue), anionic residues (red) and polar residues (grey) at 
physiological pH. Lysine residues are indicated with single amino acid codes and residue numbers.
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Table 2.  Physical properties of the circular bacteriocins with solved structures. a Predicted for the linear 
bacteriocin using ExPASy ProtParam Tool (https ://web.expas y.org/cgi-bin/compu te_pi/pi_tool). b Grand 
average of hydrophathy.
Bacteriocin Leader peptide (aa) Mature peptide (aa) MW (Da) pIa Net charge
Hydrophobicity 
(GRAVY Index)b Producer organism References
Family I
Enterocin AS-48 35 70 7150 10.1 + 6 0.539 Enterococcus faecalis AS-48 Samyn, et al.
16
Carnocyclin A 4 60 5862 10.0 + 4 1.058 Carnobacterium mal-taromaticum UAL 307 Martin-Visscher, et al.
18
Enterocin NKR-5-3B 23 64 6317 9.9 + 5 0.953 Enterococcus faecium NKR-5–3 Himeno, et al.
13
Family II
Plantacyclin B21AG 33 58 5668 10.0 + 3 1.002 Lactiplantibacillus plantarum B21 Golneshin, et al.
31
Acidocin B 33 58 5622 6.8 + 1 1.036 Lactobacillus acidophi-lus M46 Acedo, et al.
28
Figure 3.  Structural alignment of plantacyclin B21AG (green) with enterocin NKR-5-3B (blue), enterocin 
AS-48 (magenta), carnocyclin A (yellow) and acidocin B (orange). The helices are labelled accordingly using 
plantacyclin B21AG as reference.
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Plantacyclin B21AG shares 65% sequence identity with acidocin B (Fig. 4), and both belong to the circular 
bacteriocin family II. As indicated above, the NMR structure of acidocin B was determined in the presence of 
SDS  micelles28. Not surprisingly, the structure of plantacyclin B21AG (determined in aqueous conditions) did 
not align well with that of acidocin B, giving a r.m.s.d. of 4.95 Å across 57  Cα atoms (Fig. 3). Compared with 
aqueous conditions, SDS micelles may better mimic the bacterial membrane. Further elucidation of the crystal 
structure of plantacyclin B21AG in membrane-mimicking SDS micelle solvent system may provide a more direct 
comparison with the NMR solution structure of acidocin B and hence provide clues to the structural changes 
that occur in bacteriocin family II proteins upon membrane interaction.
Sequence analysis of circular bacteriocins. To extend the structural comparison, the sequence of plan-
tacyclin B21AG was aligned against the sequences of 18 bacteriocins that have been previously experimentally 
characterised as circular. In each case, circularisation had been confirmed structurally or validated via inde-
pendent experiments including electrospray ionization time-of-flight mass spectrometry (ESI-TOF MS) and 
peptide  sequencing12–24,26–30. The details and sequences can be found in Supplementary Table S1. Amino acid 
sequence alignment of these circular bacteriocins shows two families within the class I circular bacteriocins 
(Fig. 4), which is consistent with recent phylogenetic  analysis10. Secondary structure prediction suggests that 
these circular bacteriocins share considerable structural similarity despite sequence variation both within and 
between the two families. The results suggest that a sequence length of 69–70 residues gives a five α-helical struc-
ture whereas a bacteriocin sequence with fewer than 69 residues gives a four helical structure. Jpred secondary 
structure  prediction57 matched the experimentally determined secondary structure despite the large sequence 
diversity of the circular bacteriocins.
The position in the sequence of key amino acids such as charged, buried and aromatic residues appears to be 
conserved across the circular bacteriocin, which may hint at a key role for these residues in the protein antimicro-
bial activity. Specifically, the cationic residues located in helix α3 and α4 (helix α4 and α5 in the case of enterocin 
AS-48) in family I are predominantly but not exclusively lysine. In family II, histidine at position 11 and lysine at 
position 19 are highly conserved. These residues generally appear in polycationic clusters within the first, second, 
fourth/fifth α-helices. Upon N- to C-termini ligation, these cationic residues are brought into close proximity.
Anionic residues in the circular bacteriocins are generally conserved, with almost all being found in close 
proximity to the membrane-interacting polycationic region and aromatic residues (Fig. 4). This matches the 
pattern observed with the structurally determined circular bacteriocins (Fig. 2, right panel). The N–C linkage 
point is buried in the hydrophobic core in the majority of experimentally determined structures of circular bac-
teriocins. In family I, the N- and C-terminal residues are generally conserved, sharing common characteristics. 
For example, the N terminus of family I utilises most commonly a leucine, then valine and methionine. These are 
all hydrophobic residues which are similar in size (117–149 Da). The C terminus consists of an aromatic residue, 
either a tryptophan, tyrosine or phenylalanine. Carnocyclin A and garvicin ML are exceptions to this pattern, 
having a leucine and alanine, respectively at the C-terminus. Instead, a conserved aromatic residue is present in 
the post-ligation site for carnocyclin A and in the pre-ligation site in garvicin ML. The termini of family II are 
also highly conserved in both sequence and residue characteristics. The N-terminal residue is often isoleucine, 
or an aromatic residue, or a valine while the C terminus is an alanine in every case.
Aromatic residues are also highly conserved in family I and II and in addition to the C terminus of almost 
every family I sequence are found near the termini of predicted or confirmed α-helices. Tryptophan, pheny-
lalanine and tyrosine that flank transmembrane-associated helices in other proteins are thought to facilitate 
membrane  penetration58,59. This may also be the case for the circular bacteriocin sequences (Fig. 4). The presence 
of conserved aromatic residues near α-helices in circular bacteriocins may suggest they assist in cell membrane 
permeation and pore formation. For example,  Trp24 is essential for the biological activity of AS-48, and is located 
in a hydrophobic region that interacts with the  membrane60. Tryptophan has a preference for the interfacial 
Figure 4.  Phylogenetic tree showing the evolutionary relationship between the mature circular bacteriocin 
sequences, and their aligned sequences. Blue shows cationic residues. Red shows anionic residues. Purple shows 
aromatic residues. Dark grey highlighting shows α-helices confirmed via structural information. Light grey 
highlighting shows α-helices predicted by sequence alignment and secondary structure prediction. Underlining 
shows residues buried in protein core in experimentally determined structures. A. Sequence length of each 
protein is shown in “residues” column and number of known or predicted α-helices is shown in column labelled 
α-helices.
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region of lipid bilayers and allows penetration of  them61.  Trp24 is essential for antimicrobial killing activity of 
 gramicidin62, specifically for channel formation and  conductance63 and altering energy profiles for ion permea-
tion through long-range electrostatic  interactions59. Tyrosine and phenylalanine can also have a similar  effect64, 
with phenylalanine increasing membrane permeability of  proteins65.
Mutagenesis of key residues in plantacyclin B21AG. To confirm the importance of specific residues, 
we performed site-directed mutagenesis on aromatic and cationic residues within the mature sequence of plan-
tacyclin B21AG. These were non-synonymously substituted with alanine (Ala) to test their importance for anti-
microbial activity. Figure 5 shows the location of the three altered residues,  Phe8,  Lys19 and  Trp45. Other Ala 
substitution mutants  (Arg6 and  His11) expression plasmids were constructed, however despite multiple attempts 
to transform the DNA into L. plantarum WCFS1, no transformants were recovered. This could be partly due to 
bacteriocin toxicity to recombinant host. In general, transformation into L. plantarum WCFS1 was inefficient, 
requiring many attempts for each construct.
The MIC assay results (Table 3) showed plantacyclin B21AG-WT had a value of at least 5.2 ng/µL against 
indicator strain L. plantarum A6, indicating potent antimicrobial activity against a strain closely related to the 
bacteriocin producer. By contrast the MIC values of each variant increased, indicating that the antimicrobial 
activity is reduced. The aromatic residues  Phe8 and  Trp45 appeared to be important for MIC activity; when 
replaced with Ala mutants the MIC activity was reduced by 48 and 32-fold, respectively. Mutation of aromatic 
Figure 5.  3D crystal structure of plantacyclin B21AG mutagenesis location sites visualised in PyMOL with 
the corresponding amino acid sequence below. Orange shows the three residues  (Phe8,  Lys19 and  Trp45) non-
synonymously substituted with Ala. Colour indicates the positions of hydrophobic (yellow), polar (green), 
aromatic (purple), cationic (blue) and anionic (red) residues.
Table 3.  Results of MIC antimicrobial assay against indicator strain L. plantarum A6. One-way ANOVA 
comparing every sample was performed, followed by a post-hoc Tukey honestly significant difference test, 
with p values shown. MIC values are mean ± STD of two biological replicates. a MIC minimum inhibitory 
concentration, STD standard deviation, N/A no activity observed. Data are representative of two independent 
experiments, each in technical triplicate. # Plantacyclin B21AG-Lys19Ala bacteriocin variant is not an intact 
species, accounting for the low but measurable killing activity as implied by the MIC value.
L. plantarum WCFS1 sample MICa (ng/μL) Fold-reduction of antimicrobial activity
p value compared to plantacyclin 
B21AG-WT
Plantacyclin B21AG-WT 5.2 ± 0.0 N/A N/A
Plantacyclin B21AG-Phe8Ala 250 ± 0.0 48 **p < 0.01
Plantacyclin B21AG-Lys19Ala 666.7 ± 0.0 128 **p < 0.01
Plantacyclin B21AG-Trp45Ala 166.7 ± 0.0 32 **p < 0.01
Untransformed (–) 0 ± 0.0 N/A N/A
10 mM ammonium acetate (–) 0 ± 0.0 N/A N/A
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residues in AS-48 also increased MIC across a range of indicator strains by a minimum of 28-fold for Listeria 
monocytogenes 4032 to 168-fold for Enterococcus faecalis S-4760, supporting the notion of a similar role for these 
residues, despite distinct phylogenetic divergence (Fig. 4).
Interestingly, replacement of  Lys19 by Ala had the greatest impact on activity, reducing the antimicrobial activ-
ity by 128-fold: 667 ng/µL was required to inhibit growth of the indicator strain as no turbidity was observed in 
the overnight culture, compared to 5.2 ng/µL for the wild type. The control we used was the untransformed L. 
plantarum WCFS1 with 10 mM ammonium acetate, which demonstrated no MIC. This control confirms that 
the inhibitory activity was due to the respective bacteriocins alone. These MIC results identify an important 
functional role for  Phe8,  Trp45 and  Lys19 three highly conserved residues identified in the sequence analysis of 
circular bacteriocins (Fig. 4). The MIC results are in agreement with previous computational inferences that 
conserved aromatic and cationic residues are important for antimicrobial  activity10 of plantacyclin B21AG and 
by extension, other circular bacteriocins which share these features.
The observed masses of the wild type plantacyclin B21AG and its variants are listed in Table 4 and presented in 
Supplementary Figure S1. Notably, a mass was not identified for the plantacyclin B21AG  Lys19Ala mutant, despite 
evidence of antimicrobial activity and multiple attempts using fresh cultures and purifications. This mutant had 
a reduced antimicrobial activity compared with wild type (128-fold reduction). We suggest that substitution of 
 Lys19 with Ala may result in reduced stability of plantacyclin B21AG. This may explain why it failed to produce 
a single discrete peak on MALDI-TOF. We hypothecate that degraded fragments may still be antimicrobially 
active, accounting for the killing assay. A possible explanation is that the N–C terminal circularisation may be 
compromised in this mutant leading to increased  instability30,39.
Conclusions
We report the crystal structure of a circular bacteriocin from the food grade Lactiplantibacillus plantarum B21. 
Structural comparison of plantacyclin B21AG and other circular bacteriocins confirms that these antimicrobial 
peptides share a highly conserved core fold and secondary structure composition, despite low sequence identity. 
In the structures solved in aqueous conditions, the N and C ligation point is buried in the hydrophobic core of 
the globular structure and positioned within an α helix. Sequence alignment of plantacyclin B21AG with other 
bacteriocins that have been characterised to be circular revealed highly conserved motifs including polycationic 
regions predicted to be surface exposed that could be involved in membrane interaction, binding and destabilisa-
tion. Proximally located anionic residues could be involved in pore selectivity that drives cation flow out of the 
target cell. Another common motif was the presence of conserved aromatic residues near the N and C terminal 
ends of helices 4–5. These could be involved in membrane solubilisation, penetration and channel formation. 
Through multiple lines of evidence including sequence analysis, structure analysis, site-directed mutagenesis and 
antimicrobial activity, we demonstrated the importance of these evolutionarily conserved residues. In one case, 
substitution of residue  Lys19 to Ala resulted in 128-fold reduction of antimicrobial activity compared to the wild 
type plantacyclin B21AG. A problem encountered was the inefficient transformation efficiency of L. plantarum 
WCFS1 when transforming pTRKH2 backbone plasmids. Future work could focus on improving the efficiency 
by utilising different plasmid backbones and optimising the transformation protocol, to enable more rapid testing 
of other variants. Despite this limitation, we demonstrated that three aromatic and cationic residues have key 
functional roles in the antimicrobial activity of plantacyclin B21AG. Sequence and structure analysis suggest 
that several other conserved residues are likely to have key functional roles, these include  Arg6,  His11 and Asp22 
as well as the C and N terminal residues. Sufficient information now exists for the systematic exploration of 
structure-function relationships, towards the understanding and creation of new microbial killing activities.
Methods
Expression and purification of plantacyclin B21AG. Lactiplantibacillus plantarum B21 was inocu-
lated in 1 L of de Man, Rogosa & Sharpe (MRS) broth using a 2% inoculum (v/v). The culture was incubated 
for 16–18 h at 30 °C without shaking. The bacteriocin plantacyclin B21AG was purified from the culture super-
natant through a four-step protocol, i.e. concentration of cell free supernatant, extraction with water-saturated 
butanol, desalting through PD10 and cation exchange Fast Protein Liquid Chromatography (FPLC). After over-
night incubation, the culture was pelleted at 10,000×g for 10  min. The resulting cell free supernatant (CFS) 
was concentrated through a 10  kDa polyethersulfone membrane disc using an Amicon Stirred Cell (Merck 
Table 4.  MALDI-TOF mass determination of plantacyclin B21AG-WT and mutants. Also shown is the 
expected size and mass differences. N/A not applicable.
L. plantarum WCFS1 Sample
Expected molecular weight if 
circularised MALDI-TOF results
MALDI-TOF mass 
minus expected 
mass
Plantacyclin B21AG-WT 5667.7 5672.1 4.4
Plantacyclin B21AG-Phe8Ala 5591.6 5590.4 − 1.2
Plantacyclin B21AG-Lys19Ala 5610.6 Not identified N/A
Plantacyclin B21AG-Trp45Ala 5552.6 5550.9 − 1.7
Untransformed (–) N/A Not identified N/A
10 mM ammonium acetate (–) N/A Not identified N/A
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Millipore, Germany) to a final volume of 50 mL. The concentrated CFS was then extracted twice with ½ volume 
of water saturated butanol. The butanol fraction containing plantacyclin B21AG was dried under a fine stream 
of nitrogen to remove the butanol. The dried butanol fraction was then redissolved in 20 mM of sodium phos-
phate buffer (pH 6) and desalted using a NAP10 desalting column prepacked with Sephadex G-25 resin (GE 
healthcare, USA). Finally, the desalted protein fraction was purified using the Uno S6 prepacked monolith cation 
exchange column (12 × 53 mm, 6 mL, Bio-Rad, USA) (Supplementary Figure S2). The eluted fraction containing 
purified bacteriocin was concentrated to 4.6 mg/mL in an Amicon centrifugal filter concentrator with a 3 kDa 
cutoff membrane (Millipore) in buffer comprising 20 mM sodium phosphate (pH 6) for subsequent protein 
crystallisation.
Protein crystallisation and data collection. Protein crystallisation was performed at the UQ ROCX 
crystallisation facility at the Institute for Molecular Bioscience, University of Queensland. A JCSG-plus HT-96 
commercial screen (Molecular Dimensions, USA) was used to screen for crystallisation conditions using the 
hanging drop vapour diffusion method. Briefly, plantacyclin B21AG was dissolved in water at a concentration of 
2.3 mg/mL. Each hanging drop comprised 100 nL of purified bacteriocin and 100 nL of crystallisation solution 
and were set up using a Mosquito crystallisation robot (TTP Labtech, UK) in a 96-well format. The crystallisa-
tion trays were incubated at 20 °C in (and imaged using) a RockImager 1000 (Formulatrix, USA).
After 12 h incubation, a single crystal formed in condition F10 of JCSG screen containing 1.1 M sodium 
malonate, 0.1 M HEPES buffer pH 7.0 and 0.5% v/v Jeffamine ED-2003. A single crystal was harvested after 
13 days of incubation. X-ray diffraction experiments were performed at the micro-focus beamline (MX2) of the 
Australian  Synchrotron66. Crystals were flash-cooled and stored in liquid nitrogen before transferring to a stream 
of nitrogen gas at 100 K at the beamline. X-ray diffraction data were collected at a wavelength of 0.9537 Å using 
an EIGER-16 M detector at distance of 230.028 mm and with 0.1° oscillation and 0.1 s exposure of 0% attenuated 
beam per frame. 3600 frames of the data set were collected in 36 s. The data were processed and scaled using 
 XDS67 and  Aimless68, respectively.
Crystal structure determination and refinement. Attempts to solve the X-ray crystal structure of 
plantacyclin B21AG by molecular replacement (MR) using the NMR structure of acidocin B did not yield a solu-
tion. Instead, the phases for plantacyclin B21AG crystal structure were solved by molecular replacement (MR) 
method with a short model helix structure of 8 amino acids (polyalanine) as a search model, using the program 
Phaser in the CCP4  suite69,70. The program placed six helices in an asymmetric unit with LLG of 393. The six 
helical model was used in  SHELXE71–73 for density modification and polyala model building. The polyala model 
(109 residues in two chain) resulting from SHELXE was provided to MR phasing protocol of Auto-Rickshaw74,75 
server (https ://www.embl-hambu rg.de/Auto-Ricks haw) for phase improvement, model building and sequence 
docking. Within the software pipeline, MR was skipped and the partial model was refined in  CNS76 for B-factor 
and positional refinement. Further refinement in  REFMAC577,78 resulted in R/Rfree of 38.7%/40.1%. Density 
modification was performed in  PIRATE79 and the resulting phases were used in ARP/wARP80 for automated 
model building. The above density modification and model building procedure were repeated twice, which 
resulted in a model containing 112 residues with docked sequence in two chains. The last round of refinement 
(using REFMAC5) gave R/Rfree of 25.7%/30.5%. At this stage, the model was used for manual rebuilding and 
refinement. 56 water molecules were included where the mFo-nFc difference electron density showed a peak 
above 3σ and the modelled water made stereochemically reasonable hydrogen bonds. Final refinement was per-
formed with REFMAC5. A Ramachandran plot showed that 99.1% of the residues were in the preferred regions 
and 0.9% were in the allowed regions. The quality and geometry of the final structure were evaluated and vali-
dated using wwPDB validation  system81. Figures were prepared using  PYMOL56. Data collection and refinement 
statistics are presented in Table 1. The final refined model has been deposited in the Protein Data Bank with the 
code 6WI6 using wwPDB OneDep  system82.
Structural analysis. Superposition of Chain A and Chain B of Plantacyclin B21AG was performed using 
WinCoot 0.8.9.283. The percentage of solvent exposure of each amino acid residue was calculated using GETAREA 
1.0 beta (https ://curie .utmb.edu/getar ea.html)45, a web service provided by the Sealy Center for Structural Biol-
ogy at the University of Texas Medical Branch. The electrostatic potential surface map was calculated using the 
APBS  functionality84 in the PDB2PQR web server (version 2.1.1) (https ://nbcr-222.ucsd.edu/pdb2p qr_2.1.1/)85 
and the figures generated using Chimera 1.1486. The isoelectric focusing point of the proteins was computed 
using the Compute pI/MW tool in ExPASy (https ://web.expas y.org/compu te_pi/). Structural alignment between 
circular bacteriocins was performed using the Align function in  PyMOL56.
Circular bacteriocin sequence analysis. Plantacyclin B21AG sequence was aligned against sequences 
of bacteriocins previously characterised to be circular. The sequences were mined from NCBI database and 
aligned using Clustal Omega (https ://www.ebi.ac.uk/Tools /msa/clust alo/)87. The alignment was manually edited 
to remove gaps for figure clarity and exported to fasta format, which was converted to phylip format using 
Sequence Conversion (https ://seque nceco nvers ion.bugac o.com/conve rter/biolo gy/seque nces/fasta _to_phyli 
p.php). This was used as input into RAxML (raxmlHPC-PTHREADS-SSE3 version 8.2.10)88 using the following 
parameters for ML + rapid bootstrap analysis with 100 replicates: -T 2 -f a – × 285 -m PROTGAMMABLO-
SUM62 -p 639 -N 100.
The bipartitions output file was used in FigTree version 1.4.4 (https ://tree.bio.ed.ac.uk/softw are/figtr ee/) for 
viewing/manipulation.
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Jpred  457 (https ://www.compb io.dunde e.ac.uk/jpred /, date accessed: 2/9/18) was used for prediction of sec-
ondary structures of sequences without confirmed structures. The Jnet prediction algorithm was initially run, 
then to determine the secondary structures around the C and N termini, protein sequences were rearranged, 
and run again.
Site‑directed mutagenesis. Plasmid construct  pCycB2143 was used as a basis for mutagenesis studies. 
998 bp inserts containing site-directed mutations were generated via DNA synthesis (Biomatik), flanked with 
BamHI/PciI restriction sites and 6 base pair (bp) protection bases. These were subcloned into pCycB21, replac-
ing the wild type (WT) sequence. The details of each construct are found in Table 5.
Transformation into plantacyclin B21AG‑deficient strain. As previously shown, Lactiplantibacillus 
plantarum WCFS1 shares 99% genome identity to original plantacyclin B21AG producer L. plantarum  B2189. 
The generated constructs were transformed into Lactiplantibacillus plantarum WCFS1 (ATCC BAA-793)43 via 
 electroporation90 with some alterations. Briefly, 0.1 mL of an overnight culture was inoculated into 5 mL MRS 
media (Oxoid) containing 1% glycine and 0.75 M sorbitol. Cells were grown at 37 °C until mid-exponential 
phase  (OD600 of 1.5–3) then centrifuged at 4000×g for 5 min at 4 °C. From this point on, cells were kept on ice 
and centrifuged as above. Cells were then washed twice with a 10:1 volume of transformation solution contain-
ing 950 mM sucrose and 3.5 mM  MgCl2. Cells were resuspended in 80 µL of transformation buffer and 500 ng of 
plasmid DNA was added to cells. This mixture was then added to 0.2 cm cuvette (Bio-Rad) and electroporated 
with a Gene Pulser (Bio-Rad) with the following conditions: 2 kV, 25 μF and 400 Ω. If the time constant was ≥ 10, 
another 500 ng of DNA was added, and the electrical pulse repeated. 1 mL of MRS containing 100 mM  MgCl2 
and 0.5 M sucrose was used to quickly rescue cells from cuvette. The mixture was added to 1.5 mL microtubes 
and cells were incubated at 37 °C for 3 h, then 200 µL were spread onto MRS agar plates containing 15 µg/mL 
of erythromycin (Sigma-Aldrich). Plates were grown at 37 °C for 48 h and colonies screened via erythromycin 
resistance phenotype and Polymerase Chain Reaction (PCR). Sanger sequencing was performed on the PCR 
products using both primers to confirm the transformants, at the Griffith University DNA Sequencing Facility, 
QLD, Australia.
PCR. PCR was performed using GoTaq Green Master Mix (Promega) as per manufacturer’s instructions. 
Thermocycling conditions were as follows: Initial 2-min melting step of 95 °C, followed by 35 cycles of: 95 °C for 
15 s, 52 °C for 15 s, 72 °C for 1 min 20 s. A final extension of 72 °C for 5 min was performed.
Partial‑purification of L. plantarum WCFS1‑derived bacteriocins. After L. plantarum WCFS1 
transformants had been confirmed, they were grown for 24 h in 100 mL MRS cultures containing 15 µg/mL 
erythromycin. Untransformed L. plantarum WCFS1 cells were also grown overnight in MRS without antibiot-
ics to serve as a negative control. Cells were centrifuged at 8000×g for 10 min, then supernatant concentrated 
to 2 mL using 3 kDa Amicon Ultra-15 Centrifugal Filter Units (Merck). Supernatant was then washed 3 times 
with 15 mL 10 mM ammonium acetate to remove residual erythromycin. Concentrated supernatant was then 
n-butanol extracted as above and then removed in a rotary evaporator. The dried fraction was then resuspended 
in 10 mM ammonium acetate. Concentration of the bacteriocin from the partial purification was calculated 
using the extinction  coefficient91 and 280 nm absorbance value using the ProtParam calculator https ://www.
protp aram.net/index .html. Concentration was also evaluated with a Bradford assay, using bovine serum albu-
min as a standard to increase confidence in values generated (data not shown).
Table 5.  DNA and plasmids used in this study.
DNA name Size (bp) Modification/sequence Features References
Synthesised DNA
Phe8Ala 998 N/A BamHI/PciI restriction sites This study
Lys19Ala 998 N/A BamHI/PciI restriction sites This study
Trp45Ala 998 N/A BamHI/PciI restriction sites This study
Plasmids
pCycB21 10,126 N/A Plantacyclin B21AG synthesis cluster,  Em
R, E. coli and Lactobacillus 
replication Gor, et al.
43
pCycB21-Phe8Ala 10,126 Phe8Ala ligated to pCycB21 BamHI/PciI Plantacyclin B21AG synthesis cluster,  Em
R, E. coli and Lactobacillus 
replication This study
pCycB21-Lys19Ala 10,126 Lys19Ala ligated to pCycB21 BamHI/PciI Plantacyclin B21AG synthesis cluster,  Em
R, E. coli and Lactobacillus 
replication This study
pCycB21-Trp45Ala 10,126 Trp45Ala ligated to pCycB21 BamHI/PciI Plantacyclin B21AG synthesis cluster,  Em
R, E. coli and Lactobacillus 
replication This study
Primers
M13 F 17 GTA AAA CGA CGG CCAGT Used in diagnostic PCR with B21AG_Seq R to produce 1167 bp product Standard primer
B21AG_Seq R 31 CAA TAA TTG TAA TGA CAC GTA CTA ACA TAT C Used in diagnostic PCR with M13 F to produce 1167 bp product This study
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Mass analysis using MALDI‑TOF MS. Samples were analysed in a buffer containing 10 mM ammonium 
acetate with 0.1% formic acid. Analysis was performed on a ABSciex MALDI 5800 at the Mass Spectrometry 
Facility, University of Queensland, Centre for Clinical Research, QLD, Australia. A Bacterial Test Standard 
(Bruker) was used to calibrate the instrument. Partially purified supernatant from L. plantarum WCFS1 untrans-
formed (–) was used as a negative control along with 10 mM ammonium acetate with 0.1% formic acid.
Minimum inhibitory concentration assays of partially purified site‑directed mutants. After 
partial-purification, the minimum inhibitory concentration (MIC) of the plantacyclin B21AG-WT and mutants 
were evaluated. WT refers to the bacteriocin produced by L. plantarum WCFS1 transformed with pCycB21 
rather than native producer L. plantarum B21, herein this manuscript referred to as plantacyclin B21AG.
MIC assays were performed in clear 96 well plates (Greiner). 150 µL MRS containing 3 × 105 CFU/mL of 
indicator strain L. plantarum  A692,93 were added to wells. Partially purified bacteriocin samples were examined 
by making dilutions in 150 µL 10 mM ammonium acetate, then added to the wells. 1:2 serial dilutions of the 
bacteriocin were performed, evaluating each plantacyclin B21AG mutant from 1000 to 5.2 ng/µL. Supernatant 
from L. plantarum WCFS1 untransformed (–) and 10 mM ammonium acetate without bacteriocin were used 
as a bacteriocin negative controls. 10 mM ammonium acetate without bacteriocin or indicator strain was used 
as a blanking control. Plates were incubated at 37 °C for 24 h and read using a Synergy 2 (BioTek) plate reader 
at 600 nm absorbance. Assays were performed in biological duplicate, each in technical triplicate. MIC value 
was determined at the minimum concentration of bacteriocin where no growth of L. plantarum A6 occurred.
Statistical analysis. The results of the MIC assay were analysed via a One-way ANOVA and post-hoc 
Tukey honestly significant difference test using the tool at https ://astat sa.com/OneWa y_Anova _with_Tukey 
HSD/_get_data/, date accessed: 17/9/20).
Data availability
The plantacyclin B21AG crystal structure coordinates and structure factors are available in the Protein Data 
Bank repository with a PDB code 6WI6, [https ://www.rcsb.org/].
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